Praveen Tipirneni
Chief Executive Officer bei MORPHIC HOLDING, INC.
Vermögen: 23 Mio $ am 31.03.2024
Profil
Praveen P.
Tipirneni is currently the Chief Executive Officer & Director at Morphic Therapeutic, Inc. and Morphic Holding, Inc. He is also a Director at Tectonic Therapeutic, Inc. and an Independent Director at Panacea Acquisition Corp.
II.
Previously, he served as the Chief Executive Officer & Director at Morphic Holding, Inc. from 2015 to 2023.
He also held positions as Principal at Sun Microsystems, Inc. and Fusion MPHC Group, Inc. (Delaware), as well as Corporate Development Manager at Deltagen, Inc. Prior to that, he was the Senior VP-Corporate Development & Global Strategy at Cubist Pharmaceuticals LLC from 2002 to 2015.
Dr. Tipirneni holds a doctorate degree from McGill University, an undergraduate degree from Massachusetts Institute of Technology, and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
1,31% | 16.01.2024 | 655 230 ( 1,31% ) | 23 Mio $ | 31.03.2024 |
Aktive Positionen von Praveen Tipirneni
| Unternehmen | Position | Beginn |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Director/Board Member | 06.04.2021 |
| MORPHIC HOLDING, INC. | Chief Executive Officer | 02.01.2024 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Executive Officer | 01.01.2015 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Director/Board Member | - |
Ehemalige bekannte Positionen von Praveen Tipirneni
| Unternehmen | Position | Ende |
|---|---|---|
| MORPHIC HOLDING, INC. | Chief Executive Officer | 01.11.2023 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01.02.2015 |
| DELTAGEN INC. | Corporate Officer/Principal | - |
Fusion MPHC Group, Inc. (Delaware)
 Fusion MPHC Group, Inc. (Delaware) Specialty TelecommunicationsCommunications Fusion MPHC Group, Inc. provides integrated voice and data communication services. It offers broadband Internet access service for small and mid-sized businesses; business phone and Internet services; VPN and security services; email and web hosting services; and enterprise solutions. The firm also provides voice over IP, wireless and voice services on a managed national broadband network, wholesale and carrier services. The company is headquartered in DE. | Corporate Officer/Principal | - |
Sun Microsystems, Inc.
 Sun Microsystems, Inc. SemiconductorsElectronic Technology Sun Microsystems, Inc. provides network computing infrastructure solutions. It offers its solutions under the Java technology platform, Solaris Operating System, MySQL database management system, Sun StorageTek storage solutions, and UltraSPARC processor brands. The company also develops networking computing products and technologies which include servers, storage, open source software, tools, and training. The company provides solutions to the social networking, entertainment, financial services, manufacturing, healthcare, retail, news, energy, and engineering companies. The company was founded in 1982 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Ausbildung von Praveen Tipirneni
| McGill University | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Sun Microsystems, Inc.
Sun Microsystems, Inc. SemiconductorsElectronic Technology Sun Microsystems, Inc. provides network computing infrastructure solutions. It offers its solutions under the Java technology platform, Solaris Operating System, MySQL database management system, Sun StorageTek storage solutions, and UltraSPARC processor brands. The company also develops networking computing products and technologies which include servers, storage, open source software, tools, and training. The company provides solutions to the social networking, entertainment, financial services, manufacturing, healthcare, retail, news, energy, and engineering companies. The company was founded in 1982 and is headquartered in Santa Clara, CA. | Electronic Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Fusion MPHC Group, Inc. (Delaware)
Fusion MPHC Group, Inc. (Delaware) Specialty TelecommunicationsCommunications Fusion MPHC Group, Inc. provides integrated voice and data communication services. It offers broadband Internet access service for small and mid-sized businesses; business phone and Internet services; VPN and security services; email and web hosting services; and enterprise solutions. The firm also provides voice over IP, wireless and voice services on a managed national broadband network, wholesale and carrier services. The company is headquartered in DE. | Communications |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Commercial Services |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Panacea Acquisition Corp. II operates as a blank check company. It seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 14, 2021 and is headquartered in San Francisco, CA. | Finance |
